Logo image of CHTR

CHARTER COMMUNICATIONS INC-A (CHTR) Stock Fundamental Analysis

NASDAQ:CHTR - Nasdaq - US16119P1084 - Common Stock - Currency: USD

361  -2.01 (-0.55%)

After market: 361 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CHTR. CHTR was compared to 93 industry peers in the Media industry. CHTR has an excellent profitability rating, but there are concerns on its financial health. CHTR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CHTR had positive earnings in the past year.
CHTR had a positive operating cash flow in the past year.
CHTR had positive earnings in each of the past 5 years.
Each year in the past 5 years CHTR had a positive operating cash flow.
CHTR Yearly Net Income VS EBIT VS OCF VS FCFCHTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.39%, CHTR is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
With an excellent Return On Equity value of 32.61%, CHTR belongs to the best of the industry, outperforming 94.25% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.47%, CHTR is doing good in the industry, outperforming 77.01% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHTR is in line with the industry average of 7.01%.
The 3 year average ROIC (7.28%) for CHTR is below the current ROIC(7.47%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.39%
ROE 32.61%
ROIC 7.47%
ROA(3y)3.33%
ROA(5y)3.1%
ROE(3y)43.05%
ROE(5y)35.16%
ROIC(3y)7.28%
ROIC(5y)6.64%
CHTR Yearly ROA, ROE, ROICCHTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

1.3 Margins

Looking at the Profit Margin, with a value of 9.23%, CHTR belongs to the top of the industry, outperforming 81.61% of the companies in the same industry.
CHTR's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 24.04%, CHTR belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
In the last couple of years the Operating Margin of CHTR has grown nicely.
CHTR's Gross Margin of 46.53% is in line compared to the rest of the industry. CHTR outperforms 51.72% of its industry peers.
In the last couple of years the Gross Margin of CHTR has grown nicely.
Industry RankSector Rank
OM 24.04%
PM (TTM) 9.23%
GM 46.53%
OM growth 3Y4.61%
OM growth 5Y10.72%
PM growth 3Y0.82%
PM growth 5Y20.42%
GM growth 3Y1.1%
GM growth 5Y1.69%
CHTR Yearly Profit, Operating, Gross MarginsCHTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

CHTR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CHTR has less shares outstanding
CHTR has less shares outstanding than it did 5 years ago.
CHTR has a better debt/assets ratio than last year.
CHTR Yearly Shares OutstandingCHTR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CHTR Yearly Total Debt VS Total AssetsCHTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 0.74, we must say that CHTR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.74, CHTR is in line with its industry, outperforming 41.38% of the companies in the same industry.
CHTR has a debt to FCF ratio of 30.30. This is a negative value and a sign of low solvency as CHTR would need 30.30 years to pay back of all of its debts.
The Debt to FCF ratio of CHTR (30.30) is comparable to the rest of the industry.
CHTR has a Debt/Equity ratio of 6.03. This is a high value indicating a heavy dependency on external financing.
CHTR has a worse Debt to Equity ratio (6.03) than 87.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.03
Debt/FCF 30.3
Altman-Z 0.74
ROIC/WACC0.99
WACC7.53%
CHTR Yearly LT Debt VS Equity VS FCFCHTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

A Current Ratio of 0.31 indicates that CHTR may have some problems paying its short term obligations.
CHTR has a Current ratio of 0.31. This is amonst the worse of the industry: CHTR underperforms 97.70% of its industry peers.
A Quick Ratio of 0.31 indicates that CHTR may have some problems paying its short term obligations.
CHTR's Quick ratio of 0.31 is on the low side compared to the rest of the industry. CHTR is outperformed by 97.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
CHTR Yearly Current Assets VS Current LiabilitesCHTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

CHTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.46%, which is quite good.
The Earnings Per Share has been growing by 35.98% on average over the past years. This is a very strong growth
CHTR shows a small growth in Revenue. In the last year, the Revenue has grown by 0.88%.
The Revenue has been growing slightly by 3.78% on average over the past years.
EPS 1Y (TTM)16.46%
EPS 3Y12.08%
EPS 5Y35.98%
EPS Q2Q%42.86%
Revenue 1Y (TTM)0.88%
Revenue growth 3Y2.15%
Revenue growth 5Y3.78%
Sales Q2Q%1.57%

3.2 Future

The Earnings Per Share is expected to grow by 11.42% on average over the next years. This is quite good.
The Revenue is expected to grow by 0.81% on average over the next years.
EPS Next Y10%
EPS Next 2Y12.3%
EPS Next 3Y11.65%
EPS Next 5Y11.42%
Revenue Next Year0.06%
Revenue Next 2Y0.63%
Revenue Next 3Y0.65%
Revenue Next 5Y0.81%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHTR Yearly Revenue VS EstimatesCHTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
CHTR Yearly EPS VS EstimatesCHTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 20 40 60

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.33, the valuation of CHTR can be described as reasonable.
CHTR's Price/Earnings ratio is a bit cheaper when compared to the industry. CHTR is cheaper than 75.86% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CHTR is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.39, the valuation of CHTR can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CHTR is valued cheaply inside the industry as 81.61% of the companies are valued more expensively.
CHTR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 10.33
Fwd PE 9.39
CHTR Price Earnings VS Forward Price EarningsCHTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHTR is valued a bit cheaper than the industry average as 75.86% of the companies are valued more expensively.
CHTR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 16.21
EV/EBITDA 6.66
CHTR Per share dataCHTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 -200 -400

4.3 Compensation for Growth

CHTR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CHTR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.03
PEG (5Y)0.29
EPS Next 2Y12.3%
EPS Next 3Y11.65%

0

5. Dividend

5.1 Amount

No dividends for CHTR!.
Industry RankSector Rank
Dividend Yield N/A

CHARTER COMMUNICATIONS INC-A

NASDAQ:CHTR (2/21/2025, 4:50:36 PM)

After market: 361 0 (0%)

361

-2.01 (-0.55%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)01-31 2025-01-31/bmo
Earnings (Next)04-24 2025-04-24/bmo
Inst Owners73.77%
Inst Owner Change0.02%
Ins Owners0.26%
Ins Owner Change0.12%
Market Cap51.24B
Analysts68.39
Price Target406.43 (12.58%)
Short Float %13.11%
Short Ratio10.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.09%
Min EPS beat(2)0.34%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)0.98%
Min EPS beat(4)-6.59%
Max EPS beat(4)5.84%
EPS beat(8)5
Avg EPS beat(8)-3.45%
EPS beat(12)7
Avg EPS beat(12)-2.01%
EPS beat(16)10
Avg EPS beat(16)1.1%
Revenue beat(2)0
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)-1.01%
Revenue beat(4)0
Avg Revenue beat(4)-1.58%
Min Revenue beat(4)-2.42%
Max Revenue beat(4)-1.01%
Revenue beat(8)0
Avg Revenue beat(8)-1.93%
Revenue beat(12)0
Avg Revenue beat(12)-1.95%
Revenue beat(16)0
Avg Revenue beat(16)-1.76%
PT rev (1m)-2.83%
PT rev (3m)9.1%
EPS NQ rev (1m)-2.25%
EPS NQ rev (3m)10.56%
EPS NY rev (1m)3.79%
EPS NY rev (3m)5.38%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)0.5%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 10.33
Fwd PE 9.39
P/S 0.93
P/FCF 16.21
P/OCF 3.55
P/B 3.29
P/tB N/A
EV/EBITDA 6.66
EPS(TTM)34.96
EY9.68%
EPS(NY)38.46
Fwd EY10.65%
FCF(TTM)22.27
FCFY6.17%
OCF(TTM)101.66
OCFY28.16%
SpS388.06
BVpS109.81
TBVpS-581.36
PEG (NY)1.03
PEG (5Y)0.29
Profitability
Industry RankSector Rank
ROA 3.39%
ROE 32.61%
ROCE 9.7%
ROIC 7.47%
ROICexc 7.49%
ROICexgc 26.47%
OM 24.04%
PM (TTM) 9.23%
GM 46.53%
FCFM 5.74%
ROA(3y)3.33%
ROA(5y)3.1%
ROE(3y)43.05%
ROE(5y)35.16%
ROIC(3y)7.28%
ROIC(5y)6.64%
ROICexc(3y)7.31%
ROICexc(5y)6.67%
ROICexgc(3y)28.68%
ROICexgc(5y)27.6%
ROCE(3y)9.43%
ROCE(5y)8.59%
ROICexcg growth 3Y-3.91%
ROICexcg growth 5Y7.76%
ROICexc growth 3Y4.9%
ROICexc growth 5Y14.13%
OM growth 3Y4.61%
OM growth 5Y10.72%
PM growth 3Y0.82%
PM growth 5Y20.42%
GM growth 3Y1.1%
GM growth 5Y1.69%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 6.03
Debt/FCF 30.3
Debt/EBITDA 4.29
Cap/Depr 129.93%
Cap/Sales 20.46%
Interest Coverage 2.48
Cash Conversion 65.84%
Profit Quality 62.19%
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z 0.74
F-Score8
WACC7.53%
ROIC/WACC0.99
Cap/Depr(3y)121.02%
Cap/Depr(5y)104.24%
Cap/Sales(3y)19.39%
Cap/Sales(5y)17.67%
Profit Quality(3y)81.59%
Profit Quality(5y)130.29%
High Growth Momentum
Growth
EPS 1Y (TTM)16.46%
EPS 3Y12.08%
EPS 5Y35.98%
EPS Q2Q%42.86%
EPS Next Y10%
EPS Next 2Y12.3%
EPS Next 3Y11.65%
EPS Next 5Y11.42%
Revenue 1Y (TTM)0.88%
Revenue growth 3Y2.15%
Revenue growth 5Y3.78%
Sales Q2Q%1.57%
Revenue Next Year0.06%
Revenue Next 2Y0.63%
Revenue Next 3Y0.65%
Revenue Next 5Y0.81%
EBIT growth 1Y5.91%
EBIT growth 3Y6.86%
EBIT growth 5Y14.9%
EBIT Next Year72.33%
EBIT Next 3Y21.65%
EBIT Next 5Y14.09%
FCF growth 1Y-4.73%
FCF growth 3Y-28.38%
FCF growth 5Y-7.04%
OCF growth 1Y-0.02%
OCF growth 3Y-3.86%
OCF growth 5Y4.2%